HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
C Triplitt Selected Research
C Triplitt Research Topics
Disease
5
Type 2 Diabetes Mellitus (MODY)
11/2021 - 06/2011
5
Insulin Resistance
03/2015 - 12/2001
2
Weight Gain
03/2015 - 10/2011
2
Weight Loss (Weight Reduction)
03/2015 - 10/2011
1
Hypoglycemia (Reactive Hypoglycemia)
01/2015
1
Hyperglycemia
06/2011
1
Inflammation (Inflammations)
05/2011
1
Albuminuria
12/2007
Drug/Important Bio-Agent (IBA)
4
Glucose (Dextrose)
FDA Link
Generic
03/2015 - 12/2007
3
Exenatide (Byetta)
FDA Link
11/2021 - 06/2011
2
Insulin Glargine (Lantus)
FDA Link
11/2021 - 03/2015
2
Hypoglycemic Agents (Hypoglycemics)
IBA
11/2021 - 01/2015
2
Pioglitazone (Actos)
FDA Link
11/2021 - 03/2015
2
Pharmaceutical Preparations
IBA
11/2021 - 03/2015
2
Metformin (Glucophage)
FDA Link
Generic
11/2021 - 03/2015
2
Insulin (Novolin)
FDA Link
06/2011 - 05/2011
2
Rosiglitazone (Avandia)
FDA Link
12/2007 - 12/2001
2
Nonesterified Fatty Acids (NEFA)
IBA
12/2007 - 12/2001
1
Glipizide (Glucotrol)
FDA Link
Generic
11/2021
1
Glycated Hemoglobin (Glycosylated Hemoglobin)
IBA
11/2021
1
Dipeptidyl-Peptidase IV Inhibitors
IBA
01/2015
1
empagliflozin
IBA
01/2015
1
Linagliptin
IBA
01/2015
1
5'-palmitoyl cytarabine (PLAC)
IBA
10/2011
1
muraglitazar
IBA
10/2011
1
Peroxisome Proliferator-Activated Receptors (PPAR)
IBA
10/2011
1
Biomarkers (Surrogate Marker)
IBA
05/2011
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
12/2007
1
Adiponectin
IBA
12/2007
Therapy/Procedure
4
Therapeutics
11/2021 - 05/2011
1
Glycemic Control
05/2011